| Stage | MDT | % of rev | LOW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $26.0B | 100.00% | LOW ×2.66 |
| Gross profit | $6.3B | 64.99% | $8.6B | 33.04% | MDT +31.9pp |
| Operating income | $1.8B | 18.08% | $3.5B | 13.67% | MDT +4.4pp |
| Pre-tax income | $1.8B | 18.13% | $3.2B | 12.23% | MDT +5.9pp |
| Net income | $1.5B | 15.16% | $2.4B | 9.24% | MDT +5.9pp |
| Stage | MDT | LOW | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $26.0B100.00% | LOW ×2.66 |
| Gross profit | 64.99%$6.3B | 33.04%$8.6B | MDT +31.9pp |
| Operating income | 18.08%$1.8B | 13.67%$3.5B | MDT +4.4pp |
| Pre-tax income | 18.13%$1.8B | 12.23%$3.2B | MDT +5.9pp |
| Net income |
| 15.16%$1.5B |
| 9.24%$2.4B |
| MDT +5.9pp |
No shared counterparties.